Detalhe da pesquisa
1.
Initiation of Trastuzumab by Women Younger Than 64 Years for Adjuvant Treatment of Stage I-III Breast Cancer.
J Natl Compr Canc Netw
; 15(5): 601-607, 2017 05.
Artigo
Inglês
| MEDLINE | ID: mdl-28476740
2.
BRE12-158: A Postneoadjuvant, Randomized Phase II Trial of Personalized Therapy Versus Treatment of Physician's Choice for Patients With Residual Triple-Negative Breast Cancer.
J Clin Oncol
; 40(4): 345-355, 2022 02 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34910554
3.
Association of Circulating Tumor DNA and Circulating Tumor Cells After Neoadjuvant Chemotherapy With Disease Recurrence in Patients With Triple-Negative Breast Cancer: Preplanned Secondary Analysis of the BRE12-158 Randomized Clinical Trial.
JAMA Oncol
; 6(9): 1410-1415, 2020 09 01.
Artigo
Inglês
| MEDLINE | ID: mdl-32644110
4.
Topical estrogen prescribing patterns for urogenital atrophy among women with breast cancer: results of a national provider survey.
Menopause
; 26(7): 714-719, 2019 07.
Artigo
Inglês
| MEDLINE | ID: mdl-30939535